vs
SSR MINING INC.（SSRM）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
West Pharmaceutical Services的季度营收约是SSR MINING INC.的1.5倍（$805.0M vs $521.7M），SSR MINING INC.净利率更高（34.8% vs 16.4%，领先18.4%），SSR MINING INC.同比增速更快（61.4% vs 7.5%），West Pharmaceutical Services自由现金流更多（$175.0M vs $106.4M），过去两年SSR MINING INC.的营收复合增速更高（50.5% vs 7.6%）
SSR Mining Inc.（前身为白银标准资源公司）总部位于美国科罗拉多州丹佛，主营金、银、铜、铅、锌矿产开采，拥有阿根廷最大的银矿，同时在美洲全境及土耳其开展矿产勘探业务。2020年与阿拉瑟黄金合并后迁至丹佛，现任总裁兼首席执行官为罗德尼·P·安塔尔。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
SSRM vs WST — 直观对比
营收规模更大
WST
是对方的1.5倍
$521.7M
营收增速更快
SSRM
高出53.9%
7.5%
净利率更高
SSRM
高出18.4%
16.4%
自由现金流更多
WST
多$68.6M
$106.4M
两年增速更快
SSRM
近两年复合增速
7.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $521.7M | $805.0M |
| 净利润 | $181.5M | $132.1M |
| 毛利率 | — | 37.8% |
| 营业利润率 | 38.8% | 19.5% |
| 净利率 | 34.8% | 16.4% |
| 营收同比 | 61.4% | 7.5% |
| 净利润同比 | 3166.6% | 1.5% |
| 每股收益（稀释后） | $0.84 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SSRMWST
| Q4 25 | $521.7M | $805.0M | ||
| Q3 25 | $385.8M | $804.6M | ||
| Q2 25 | $405.5M | $766.5M | ||
| Q1 25 | $316.6M | $698.0M | ||
| Q4 24 | $323.2M | $748.8M | ||
| Q3 24 | $257.4M | $746.9M | ||
| Q2 24 | $184.8M | $702.1M | ||
| Q1 24 | $230.2M | $695.4M |
净利润SSRMWST
| Q4 25 | $181.5M | $132.1M | ||
| Q3 25 | $65.4M | $140.0M | ||
| Q2 25 | $90.1M | $131.8M | ||
| Q1 25 | $58.8M | $89.8M | ||
| Q4 24 | $5.6M | $130.1M | ||
| Q3 24 | $10.6M | $136.0M | ||
| Q2 24 | $9.7M | $111.3M | ||
| Q1 24 | $-287.1M | $115.3M |
毛利率SSRMWST
| Q4 25 | — | 37.8% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 35.7% | ||
| Q1 25 | — | 33.2% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 35.4% | ||
| Q2 24 | — | 32.8% | ||
| Q1 24 | — | 33.1% |
营业利润率SSRMWST
| Q4 25 | 38.8% | 19.5% | ||
| Q3 25 | 21.6% | 20.8% | ||
| Q2 25 | 26.9% | 20.1% | ||
| Q1 25 | 21.1% | 15.3% | ||
| Q4 24 | 10.6% | 21.3% | ||
| Q3 24 | 3.5% | 21.6% | ||
| Q2 24 | 5.8% | 18.0% | ||
| Q1 24 | -163.5% | 17.7% |
净利率SSRMWST
| Q4 25 | 34.8% | 16.4% | ||
| Q3 25 | 17.0% | 17.4% | ||
| Q2 25 | 22.2% | 17.2% | ||
| Q1 25 | 18.6% | 12.9% | ||
| Q4 24 | 1.7% | 17.4% | ||
| Q3 24 | 4.1% | 18.2% | ||
| Q2 24 | 5.2% | 15.9% | ||
| Q1 24 | -124.7% | 16.6% |
每股收益（稀释后）SSRMWST
| Q4 25 | $0.84 | $1.82 | ||
| Q3 25 | $0.31 | $1.92 | ||
| Q2 25 | $0.42 | $1.82 | ||
| Q1 25 | $0.28 | $1.23 | ||
| Q4 24 | $0.03 | $1.78 | ||
| Q3 24 | $0.05 | $1.85 | ||
| Q2 24 | $0.05 | $1.51 | ||
| Q1 24 | $-1.42 | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $575.6M | $791.3M |
| 总债务越低越好 | — | $202.8M |
| 股东权益账面价值 | $3.5B | $3.2B |
| 总资产 | $6.1B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资SSRMWST
| Q4 25 | $575.6M | $791.3M | ||
| Q3 25 | $445.4M | $628.5M | ||
| Q2 25 | $438.5M | $509.7M | ||
| Q1 25 | $341.3M | $404.2M | ||
| Q4 24 | $417.3M | $484.6M | ||
| Q3 24 | $365.8M | $490.9M | ||
| Q2 24 | $384.4M | $446.2M | ||
| Q1 24 | $492.0M | $601.8M |
总债务SSRMWST
| Q4 25 | — | $202.8M | ||
| Q3 25 | — | $202.7M | ||
| Q2 25 | — | $202.6M | ||
| Q1 25 | — | $202.6M | ||
| Q4 24 | $228.6M | $202.6M | ||
| Q3 24 | $228.3M | $202.6M | ||
| Q2 24 | $228.0M | $205.8M | ||
| Q1 24 | $228.7M | $206.2M |
股东权益SSRMWST
| Q4 25 | $3.5B | $3.2B | ||
| Q3 25 | $3.3B | $3.1B | ||
| Q2 25 | $3.3B | $2.9B | ||
| Q1 25 | $3.2B | $2.7B | ||
| Q4 24 | $3.1B | $2.7B | ||
| Q3 24 | $3.1B | $2.8B | ||
| Q2 24 | $3.1B | $2.6B | ||
| Q1 24 | $3.1B | $2.7B |
总资产SSRMWST
| Q4 25 | $6.1B | $4.3B | ||
| Q3 25 | $5.9B | $4.1B | ||
| Q2 25 | $5.8B | $4.0B | ||
| Q1 25 | $5.6B | $3.6B | ||
| Q4 24 | $5.2B | $3.6B | ||
| Q3 24 | $5.1B | $3.7B | ||
| Q2 24 | $5.2B | $3.5B | ||
| Q1 24 | $5.3B | $3.6B |
负债/权益比SSRMWST
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | 0.07× | 0.08× | ||
| Q3 24 | 0.07× | 0.07× | ||
| Q2 24 | 0.07× | 0.08× | ||
| Q1 24 | 0.07× | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.1M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $106.4M | $175.0M |
| 自由现金流率自由现金流/营收 | 20.4% | 21.7% |
| 资本支出强度资本支出/营收 | 12.6% | 9.5% |
| 现金转化率经营现金流/净利润 | 0.95× | 1.90× |
| 过去12个月自由现金流最近4个季度 | $241.6M | $468.9M |
8季度趋势，按日历期对齐
经营现金流SSRMWST
| Q4 25 | $172.1M | $251.1M | ||
| Q3 25 | $57.2M | $197.2M | ||
| Q2 25 | $157.8M | $177.1M | ||
| Q1 25 | $84.8M | $129.4M | ||
| Q4 24 | $95.0M | $190.1M | ||
| Q3 24 | $-1.3M | $180.1M | ||
| Q2 24 | $-78.1M | $165.0M | ||
| Q1 24 | $24.6M | $118.2M |
自由现金流SSRMWST
| Q4 25 | $106.4M | $175.0M | ||
| Q3 25 | $-2.4M | $133.9M | ||
| Q2 25 | $98.4M | $101.9M | ||
| Q1 25 | $39.3M | $58.1M | ||
| Q4 24 | $56.4M | $85.2M | ||
| Q3 24 | $-34.1M | $98.8M | ||
| Q2 24 | $-116.3M | $64.8M | ||
| Q1 24 | $-9.4M | $27.6M |
自由现金流率SSRMWST
| Q4 25 | 20.4% | 21.7% | ||
| Q3 25 | -0.6% | 16.6% | ||
| Q2 25 | 24.3% | 13.3% | ||
| Q1 25 | 12.4% | 8.3% | ||
| Q4 24 | 17.5% | 11.4% | ||
| Q3 24 | -13.2% | 13.2% | ||
| Q2 24 | -62.9% | 9.2% | ||
| Q1 24 | -4.1% | 4.0% |
资本支出强度SSRMWST
| Q4 25 | 12.6% | 9.5% | ||
| Q3 25 | 15.4% | 7.9% | ||
| Q2 25 | 14.7% | 9.8% | ||
| Q1 25 | 14.4% | 10.2% | ||
| Q4 24 | 11.9% | 14.0% | ||
| Q3 24 | 12.7% | 10.9% | ||
| Q2 24 | 20.7% | 14.3% | ||
| Q1 24 | 14.8% | 13.0% |
现金转化率SSRMWST
| Q4 25 | 0.95× | 1.90× | ||
| Q3 25 | 0.87× | 1.41× | ||
| Q2 25 | 1.75× | 1.34× | ||
| Q1 25 | 1.44× | 1.44× | ||
| Q4 24 | 17.10× | 1.46× | ||
| Q3 24 | -0.13× | 1.32× | ||
| Q2 24 | -8.06× | 1.48× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SSRM
| Gold | $369.3M | 71% |
| Concentrate Sales | $124.4M | 24% |
| Other | $19.1M | 4% |
| Lead | $9.0M | 2% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
